1 - 2 November 2018 / Potsdam-Golm, Germany
Hero Image
1 - 2 November 2018
Potsdam-Golm, Germany
10th Potsdam Days on Bioanalysis 2018

Nov 1

Challenges of developing analytics and diagnostics along the value chain



8:00

Registration and Welcome Coffee, Industrial Exhibition



Opening

9:00

Frank Bier, Head of Department

Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Potsdam-Golm, Germany

9:05

Christine Mißler, Section Manager Biotech / Pharma

Berlin Partner for Business and Technology GmbH, Berlin, Germany



Keynote

9:10

Patrick Halek, Corporate Developer   

When Cooperation Meets Innovation - How Beautiful Minds Can Connect And Create Something Grand

blueformance, Vienna, Austria



Session 1: Identification of new Biomarkers: Nothing easier than this?

9:40

Thalia Erbes, Medical Head Senology Department

Liquid biopsy based micro RNAs as innovative biomarker in the detection of breast and gynecological cancer

Klinik für Frauenheilkunde, Universitätsklinikum Freiburg, Freiburg, Germany

10:00

Karl Skriner, Head of Research Group

Protein array technology in personalised medicine: Detection of individual biomarker profiles

Charité, Medical Department, Division of Rheumatology and Clinical Immunology, Berlin, Germany



10:20

Coffee Break and Industrial Exhibition



Session 2: Development of Bioanalytical Assays: Are standard procedures sufficient?

10:50

Janko Brand, Senior Scientist

Therapeutic Drug Monitoring Assay Development: A backstage view

BioTeZ Berlin-Buch GmbH, Berlin, Germany

11:10

Helene Schulze, Business developer 

And every beginning is filled with magic - Building an innovative team right from the start

sifin diagnostics GmbH, Berlin, Germany

11:30

Nils Rohde, Head of Sales Immunoassays & POC-IT

Innovation vs. Costs & Benefits. What happens to your Value Proposition in real life?

Radiometer GmbH, Krefeld, Germany



Session 3: Sensor Systems: Nothing new on the horizon?

11:50

NN

tba

Dynamic Biosensors GmbH, Planegg, Germany

12:10

Philipp Baaske, CEO & Founder

2008-2018: A Biotech Odyssey

NanoTemper Technologies GmbH, Munich, Germany

12:30

Lars Dähne, CEO & Founder

From theory to market: Miniaturization of label-free protein analytics by means of “Whispering Gallery Mode” particles in microfluidics

Surflay Nanotec GmbH, Berlin, Germany



12:50

Lunch Break and Industrial Exhibition



Session 4: Manufacturing and Digitalization: Solution or problem?

13:50

Micaela Wochner, Head Customer Operations & Vice President

Prototypes to series – from development to commercial success

Tecan Group AG, Männedorf, Switzerland

14:10

Kevin-Louis Pawelke, CEO

Innovative cooperation between corporates and young companies on an ecosystem

M2MGo GmbH, Berlin, Germany

14:30

Norman Rzepka, CEO & Co-Founder

webKnossos: Automated Image Analysis for Brain Research

scalable minds UG, Potsdam, Germany

14:50

Elvina Kulinicenk, Management Assistant

Cloud solutions for data unification - Cooperation with external manpower

sourcestream GmbH, Berlin, Germany



Session 5: Challenges are global: Is better cooperation the solution?

15:05

Viola Muth, Section Manager Biotech / Pharma

A regional eco-system based on a collaborative approach to drive innovation & growth

Cluster Health Capital, Brandenburg Invest, WFBB, Potsdam-Golm, Germany

15:15

Jasmin Podufall, Project Manager Biotech / Pharma

Creating value in networks

Network Manager NetPhaSol, Berlin Partner for Business

and Technology, Berlin, Germany

15:25

Jörg-M. Hollidt, CEO

Co-operations in Networks: a driver for innovation in IVD

DiagnostikNet | BB, Hennigsdorf, Germany



Session 6: Impulse Lecture: Cooperations and strategic partnerships

15:35

Benno Packi, Law Firm Partner (Lawyer)

Corporate vs. financial investors – the preferable way to a success story

adesse anwälte Eckhardt & Packi Partnerschaft mbB, Berlin, Germany



15:55

Coffee Break and Industrial Exhibition



Session 7: Quo Vadis, IVD?

16:25

Eugen Ermantraut, CEO

BLINK ONE – making sharing economy work in IVD

Blink Dx AG, Jena, Germany

16:45

Vincent Zimmer, Head of Strategic Partnerships and Business Development

Some disease are rare - hope should never be. About the Diagnostic potential of AI for Rare disease

Ada Health GmbH, Berlin, Germany

17:05

Franck Molina, President of EDCA & Director of public-private research center

tba

European Diagnostic Clusters Alliance (EDCA), Brussels, Belgium



17:30

Panel Discussion

Topic: "20 years from now: how to find cooperation models to succeed"


Eugen Ermantraut • Blink Dx

Jörg-M. Hollidt • DiagnostikNet | BB

Friedhelm Kremer • ACC Group

Franck Molina • European Diagnostic Clusters Alliance

Kevin-Louis Pawelke • M2MGo

Micaela Wochner • Tecan Group



18:30

Get Together - Celebrating 20 years Fraunhofer in Potsdam



Nov 2

IVD-Regulation, Infectious Diseases, and Services



8:00

Registration and Welcome Coffee, Industrial Exhibition



BB LIFE Seminar: The new IVD-Regulation for Beginners and Specialists

Chair: Anja Kastell, Project Manager

Berlin Partner for Business and Technology, Berlin, Germany

9:00

Hans Zanker, CEO

Summary, Outline and Current Status of Realization

CE plus GmbH, Badenweiler, Germany

9:30

Frederic Becker, Development Manager - Medical Devices

and Charlotte Hess, Sales Representative Medical Devices

The Notified Body’s Perspective on the IVD-Regulation

BSI Group Deutschland GmbH, Frankfurt am Main, Germany

10:00

Johannes Tanne, Regulatory Affairs Manager

Performance Evaluation for IVD

QiP GmbH, Ludwigsfelde, Germany

10:30

Peter Wieloch, Medical Director Clinical Trials

Wrap Up and Future Prospects: Which are the influences on and challenges for the IVD-Industry?

Bioscientia Institut für Medizinische Diagnostik GmbH, Ingelheim, Germany



11:00

Coffee Break and Industrial Exhibition



3rd Status Seminar FluType: New Horizons in Infection Analysis and Diagnostics


Chair: Henry Memczak, Scientist
University of Potsdam, c/o Fraunhofer IZI-BB, Potsdam-Golm, Germany

11:30

Slobodan Paessler, Faculty Director

Bioinformatic platform to study virus evolution and predict vaccine efficac

University of Texas Medical Branch, Department of Pathology, Galveston, Texas, USA

12:15

Daniel Demminger, Scientist

and Marc Hovestädt, Scientist

Development of a peptide-based subtyping platform for influenza viruses

Robert Koch Institute - Department 1: Infectious Diseases, Berlin, Germany and University of Potsdam, c/o Fraunhofer IZI-BB, Potsdam-Golm, Germany



12:45

Lunch Break and Industrial Exhibition



Bioanalysis at Fraunhofer and Beyond



Chair: Christine Mißler, Section Manager Biotech / Pharma

Berlin Partner for Business and Technology, Berlin, Germany

13:45

Frank Bier, Head of Department

Serving the value chain: Bioanalysis at Fraunhofer in Potsdam

Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Potsdam-Golm, Germany

14:05

Agnes von Matuschka, CEO

Golm Science Park - An excellent infrastructure & community

Potsdam Golm Science Park, Potsdam, Germany

14:35Xenia Knigge, Research Associate

From idea to lab: Dielectrophoresis for the immobilization of single biomolecules

Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Potsdam-Golm, Germany

14:55

Cornelia Hettrich, Research Associate

From Lab to Application : Rapid On-Site Test of ß-Lactamase-Producing Bacteri

Fraunhofer Institute for Cell Therapy and Immunology, Branch Bioanalytics and Bioprocesses (IZI-BB), Potsdam-Golm, Germany

15:15
Robert NiedlCTO & Co-Founder

From Draft to Product: Paperbased S2R-System for Bacteria Detection

diamond inventics GmbH, Berlin, Germany

15:35

Heiko Andresen, Law Firm Partner (Patent Attorney)

From Lab to Right - Practical insights into the professional career from scientist to patent attorney

Hansepatent Patentanwälte Andresen Scholz PartG mbB - Hamburg, Germany

15:55
Closing remarks, coffee and Fraunhofer IZI-BB tour:
Fraunhofer scientists show their latest research in bioanalysis


16:30

End

Location

IAP Fraunhofer Conference Center

Organised by